1. An unexpected and devastating adverse event of dasatinib: Rhabdomyolysis. (2016) Authors: Uz, Burak; Dolasik, Ilhan Journal: Leukemia research reports Issue: Volume 5(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chronic lymphocytic lymphoma and concomitant renal cell carcinoma (Clear Cell Type): Review of the literature. (2016) Authors: Uz, Burak; Dolasik, Ilhan; Ucer, Ozlem; Dagli, Adile Ferda; Simsek, Sercan Journal: Leukemia research reports Issue: Volume 6(2016) Page Start: 8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical and pathological correlations of marrow PUMA and P53 expressions in myelodysplastic syndromes. Issue 5 (4th April 2015) Authors: Bektas, Ozlen; Uner, Aysegul; Buyukasik, Yahya; Uz, Burak; Bozkurt, Sureyya; Eliacik, Eylem; Işik, Ayse; Haznedaroglu, Ibrahim Celalettin; Goker, Hakan; Demiroglu, Haluk; Aksu, Salih; Ozcebe, Osman Ilhami; Sayinalp, Nilgun Journal: Apmis Issue: Volume 123:Issue 5(2015:May) Page Start: 445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Coexistance of JAK2V617F mutation and BCR/ABL translocation in one patient. Issue 2 (2010) Authors: Yokuş, Osman; Kurnaz, Fatih; Balçık, Özlem Şahin; Uz, Burak; Albayrak, Murat Journal: Journal of clinical and experimental investigations Issue: Volume 1:Issue 2(2010) Page Start: 138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Comment: Management of De Novo Chronic Myelogenous Leukemia and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation Tyrosine Kinase Inhibitor Dasatinib. (April 2016) Authors: Uz, Burak; Dolasik, Ilhan Journal: Annals of pharmacotherapy Issue: Volume 50:Number 4(2016:Apr.) Page Start: 334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies. Issue 10 (October 2015) Authors: Kara, Özgür; Zarakolu, Pinar; Aşçioğlu, Sibel; Etgül, Sezgin; Uz, Burak; Büyükaşik, Yahya; Akova, Murat Journal: Infectious diseases Issue: Volume 47:Issue 10(2015:Oct.) Page Start: 690 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies. Issue 10 (October 2015) Authors: Kara, Özgür; Zarakolu, Pinar; Aşçioğlu, Sibel; Etgül, Sezgin; Uz, Burak; Büyükaşik, Yahya; Akova, Murat Journal: Infectious diseases Issue: Volume 47:Issue 10(2015:Oct.) Page Start: 690 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate. (1st September 2013) Authors: Uz, Burak; Buyukasik, Yahya; Atay, Hilmi; Kelkitli, Engin; Turgut, Mehmet; Bektas, Ozlen; Eliacik, Eylem; Isik, Ayşe; Aksu, Salih; Goker, Hakan; Sayinalp, Nilgun; Ozcebe, Osman I.; Haznedaroglu, Ibrahim C. Journal: Hematology Issue: Volume 18:Number 5(2013) Page Start: 247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate. (September 2013) Authors: Uz, Burak; Buyukasik, Yahya; Atay, Hilmi; Kelkitli, Engin; Turgut, Mehmet; Bektas, Ozlen; Eliacik, Eylem; Isik, Ayşe; Aksu, Salih; Goker, Hakan; Sayinalp, Nilgun; Ozcebe, Osman I.; Haznedaroglu, Ibrahim C. Journal: Hematology Issue: Volume 18:Number 5(2013) Page Start: 247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Is end-stage renal disease always symptomatic?. Issue 3 (2010) Authors: Alkan, Rabia; Uz, Ebru; Balçık, Özlem Şahin; Uz, Burak; Bayram, Yeter Journal: Journal of clinical and experimental investigations Issue: Volume 1:Issue 3(2010) Page Start: 216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗